MAGNETOM World
MAGNETOM World
  1. MAGNETOM World
  2. Virtual 11th MAGNETOM World Summit
  3. 11th MAGNETOM World Summit
  4. Quantitative, Robust Neuro MRI

Quantitative, Robust Neuro MRI

Multi-parametric MRI in Stroke Imaging

Shan Shan Lu (First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China)

Clinical Benefits of MR Fingerprinting1

Meiyun Wang (Henan Provincial People's Hospital, China)

MRI Techniques in Multiple Sclerosis: New Diagnostic and Research Developments1

Matilde Inglese (University of Genoa, Italy / Icahn School of Medicine at Mount Sinai, New York, NY, USA)

Measuring Brain Maturation with Quantitative MRI in Pediatrics1,3

Baptiste Morel (Pediatric Radiology, Clocheville Hospital, CHRU de Tours, France)

How we do it: Pearls and Pitfalls in Clinical fMRI

Cathy Elsinger (NNL, Bergen, Norway)

Wave CAIPI for Routine Clinical Brain MRI1,3

Susie Huang (Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA, USA)

Clinical Translation of 7T MRI: Epilepsy Imaging

Srinivasan Mukundan (Brigham and Women's Hospital, Boston, MA, USA)

Graphic Recordings of lectures and sessions

Neuro Mri Graphic Recording

Quantitative, Robust Neuro MRI

The herein illustrated statements made by Siemens Healthineers’ customers are based on their own and discrete opinion. The speaker is responsible for obtaining permission to use any previously published figures or tables. The speaker is also responsible for obtaining permission to reproduce any photograph showing recognizable persons.

1

Some products/features (here mentioned) are not necessarily commercially available in all countries. Due to regulatory reasons their availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.

2

The MRI restrictions (if any) of the metal implant must be considered prior to patient undergoing MRI exam. MR imaging of patients with metallic implants brings specific risks. However, certain implants are approved by the governing regulatory bodies to be MR conditionally safe. For such implants, the previously mentioned warning may not be applicable. Please contact the implant manufacturer for the specific conditional information. The conditions for MR safety are the responsibility of the implant manufacturer, not of Siemens Healthineers.

3

MR scanning has not been established as safe for imaging fetuses and infants less than two years of age. The responsible physician must evaluate the benefits of the MR examination compared to those of other imaging procedures.

4

Work in progress: the application is currently under development and is not for sale in the U.S. and in other countries. Its future availability cannot be ensured. Note: This feature may not be available in all regions/countries at the time of publication.

5

The product is not for sale in the U.S. Its future availability cannot be guaranteed.